{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:25:47Z","timestamp":1794864347760,"version":"4.9.1"},"reference-count":300,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) and type 2 diabetes mellitus (T2DM) are two prevalent conditions that present considerable public health issue in aging populations worldwide. Recent research has proposed a novel conceptualization of AD as \u201ctype 3 diabetes\u201d, highlighting the critical roles of insulin resistance and impaired glucose metabolism in the pathogenesis of the disease. This article examines the implications of this association, exploring potential new avenues for treatment and preventive strategies for AD. Key evidence linking diabetes to AD emphasizes critical metabolic processes that contribute to neurodegeneration, including inflammation, oxidative stress, and alterations in insulin signaling pathways. By framing AD within this metabolic context, we can enhance our understanding of its etiology, which in turn may influence early diagnosis, treatment plans, and preventive measures. Understanding AD as a manifestation of diabetes opens up the possibility of employing novel therapeutic strategies that incorporate lifestyle modifications and the use of antidiabetic medications to mitigate cognitive decline. This integrated approach has the potential to improve patient outcomes and deepen our comprehension of the intricate relationship between neurodegenerative diseases and metabolic disorders.<\/jats:p>","DOI":"10.3390\/ijms252211955","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:22:56Z","timestamp":1730953376000},"page":"11955","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Alzheimer\u2019s Disease as Type 3 Diabetes: Understanding the Link and Implications"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8616-3825","authenticated-orcid":false,"given":"Mateusz","family":"Kciuk","sequence":"first","affiliation":[{"name":"Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha Street 12\/16, 90-237 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1699-8912","authenticated-orcid":false,"given":"Weronika","family":"Kruczkowska","sequence":"additional","affiliation":[{"name":"Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3377-4162","authenticated-orcid":false,"given":"Julia","family":"Ga\u0142\u0119ziewska","sequence":"additional","affiliation":[{"name":"Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9010-8493","authenticated-orcid":false,"given":"Katarzyna","family":"Wanke","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha Street 12\/16, 90-237 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2335-3293","authenticated-orcid":false,"given":"\u017baneta","family":"Ka\u0142uzi\u0144ska-Ko\u0142at","sequence":"additional","affiliation":[{"name":"Department of Functional Genomics, Medical University of Lodz, 90-752 Lodz, Poland"},{"name":"Department of Biomedicine and Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-7662","authenticated-orcid":false,"given":"Marta","family":"Aleksandrowicz","sequence":"additional","affiliation":[{"name":"Laboratory of Preclinical Research and Environmental Agents, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2859-9839","authenticated-orcid":false,"given":"Renata","family":"Kontek","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha Street 12\/16, 90-237 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"ref_1","first-page":"e12334","article-title":"Alzheimer\u2019s Disease Diagnosis and Management: Perspectives from around the World","volume":"14","author":"Kerwin","year":"2022","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Li, X., Feng, X., Sun, X., Hou, N., Han, F., and Liu, Y. (2022). Global, Regional, and National Burden of Alzheimer\u2019s Disease and Other Dementias, 1990\u20132019. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.937486"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s Disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodr\u00edguez, I., Cadena-Su\u00e1rez, A.R., S\u00e1nchez-Garibay, C., Pozo-Molina, G., M\u00e9ndez-Catal\u00e1, C.F., Cardenas-Aguayo, M.-D.-C., and Diaz-Cintra, S. (2023). Alzheimer\u2019s Disease: An Updated Overview of Its Genetics. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043754"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current Understanding of the Alzheimer\u2019s Disease-Associated Microbiome and Therapeutic Strategies","volume":"56","author":"Seo","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain Imaging in Alzheimer Disease","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker Changes during 20 Years Preceding Alzheimer\u2019s Disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.25259\/JNRP_356_2023","article-title":"Guidelines for Pharmacotherapy in Alzheimer\u2019s Disease\u2014A Primer on FDA-Approved Drugs","volume":"14","author":"Varadharajan","year":"2023","journal-title":"J. Neurosci. Rural. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rashad, A., Rasool, A., Shaheryar, M., Sarfraz, A., Sarfraz, Z., Robles-Velasco, K., and Cherrez-Ojeda, I. (2022). Donanemab for Alzheimer\u2019s Disease: A Systematic Review of Clinical Trials. Healthcare, 11.","DOI":"10.3390\/healthcare11010032"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2004","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes Mellitus, the Fastest Growing Global Public Health Concern: Early Detection Should Be Focused","volume":"7","author":"Hossain","year":"2024","journal-title":"Health Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kruczkowska, W., Ga\u0142\u0119ziewska, J., Kciuk, M., Gieleci\u0144ska, A., P\u0142uciennik, E., Pasieka, Z., Zhao, L.-Y., Yu, Y.-J., Ko\u0142at, D., and Ka\u0142uzi\u0144ska-Ko\u0142at, \u017b. (2024). Senescent Adipocytes and Type 2 Diabetes\u2014Current Knowledge and Perspective Concepts. Biomol. Concepts, 15.","DOI":"10.1515\/bmc-2022-0046"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100944","DOI":"10.1016\/j.arr.2019.100944","article-title":"Diabetes Mellitus and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 144 Prospective Studies","volume":"55","author":"Xue","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13098-024-01346-4","article-title":"The Relationship between Diabetes and the Dementia Risk: A Meta-Analysis","volume":"16","author":"Cao","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"afab231","DOI":"10.1093\/ageing\/afab231","article-title":"Diabetes Duration and the Risk of Dementia: A Cohort Study Based on German Health Claims Data","volume":"51","author":"Reinke","year":"2022","journal-title":"Age Ageing"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-220207","article-title":"Diabetes, Hypertension, and the Risk of Dementia","volume":"89","author":"Yen","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000064928","article-title":"Diabetes Mellitus and the Risk of Dementia, Alzheimer\u2019s Disease and Vascular Cognitive Impairment in the Canadian Study of Health and Aging","volume":"14","author":"MacKnight","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/ene.13312","article-title":"Diabetes Mellitus and Risk of Early-Onset Alzheimer\u2019s Disease: A Population-Based Case-Control Study","volume":"24","author":"Kadohara","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S104161020200844X","article-title":"Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer\u2019s Disease: A Population-Based Study of the Oldest Old","volume":"14","author":"Hassing","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Caberlotto, L., Nguyen, T.-P., Lauria, M., Priami, C., Rimondini, R., Maioli, S., Cedazo-Minguez, A., Sita, G., Morroni, F., and Corsi, M. (2019). Cross-Disease Analysis of Alzheimer\u2019s Disease and Type-2 Diabetes Highlights the Role of Autophagy in the Pathophysiology of Two Highly Comorbid Diseases. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-39828-5"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yoon, J.H., Hwang, J., Son, S.U., Choi, J., You, S.-W., Park, H., Cha, S.-Y., and Maeng, S. (2023). How Can Insulin Resistance Cause Alzheimer\u2019s Disease?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043506"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain Insulin Resistance in Alzheimer\u2019s Disease and Related Disorders: Mechanisms and Therapeutic Approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English Translation of Alzheimer\u2019s 1907 Paper, \u201cUber Eine Eigenartige Erkankung Der Hirnrinde\u201d","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin. Anat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s Disease: The Challenge of the Second Century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","article-title":"Late-Onset vs Nonmendelian Early-Onset Alzheimer Disease: A Distinction without a Difference?","volume":"6","author":"Reitz","year":"2020","journal-title":"Neurol. Genet."},{"key":"ref_26","first-page":"34","article-title":"Early-Onset Alzheimer Disease and Its Variants","volume":"25","author":"Mendez","year":"2019","journal-title":"Continuum"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/jnnp.74.9.1206","article-title":"The Prevalence and Causes of Dementia in People under the Age of 65 Years","volume":"74","author":"Harvey","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Firdaus, Z., and Li, X. (2024). Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042320"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chen, D., Wang, X., Huang, T., and Jia, J. (2022). Sleep and Late-Onset Alzheimer\u2019s Disease: Shared Genetic Risk Factors, Drug Targets, Molecular Mechanisms, and Causal Effects. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.794202"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-020-18534-1","article-title":"Risk Prediction of Late-Onset Alzheimer\u2019s Disease Implies an Oligogenic Architecture","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1007\/s00415-012-6481-y","article-title":"Comparison of Clinical Characteristics between Familial and Non-Familial Early Onset Alzheimer\u2019s Disease","volume":"259","author":"Karve","year":"2012","journal-title":"J. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.semcdb.2020.03.005","article-title":"Mechanisms of Neurodegeneration\u2014Insights from Familial Alzheimer\u2019s Disease","volume":"105","author":"Szaruga","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1007\/s12035-015-9415-8","article-title":"The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/pro.3275","article-title":"Amyloidogenesis of Tau Protein","volume":"26","author":"Nizynski","year":"2017","journal-title":"Protein Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1002\/alz.13784","article-title":"The Six Brain-Specific TAU Isoforms and Their Role in Alzheimer\u2019s Disease and Related Neurodegenerative Dementia Syndromes","volume":"20","author":"Buchholz","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet-Nocca, C., Tsvetkov, P.O., Devred, F., and Landrieu, I. (2019). Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00204"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1073\/pnas.94.1.298","article-title":"Abnormal Phosphorylation of Tau and the Mechanism of Alzheimer Neurofibrillary Degeneration: Sequestration of Microtubule-Associated Proteins 1 and 2 and the Disassembly of Microtubules by the Abnormal Tau","volume":"94","author":"Alonso","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","article-title":"Does Modulation of Tau Hyperphosphorylation Represent a Reasonable Therapeutic Strategy for Alzheimer\u2019s Disease? From Preclinical Studies to the Clinical Trials","volume":"28","author":"Basheer","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of Tau Protein in Alzheimer\u2019s Disease: The Prime Pathological Player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hammond, T.C., Xing, X., Wang, C., Ma, D., Nho, K., Crane, P.K., Elahi, F., Ziegler, D.A., Liang, G., and Cheng, Q. (2020). \u03b2-Amyloid and Tau Drive Early Alzheimer\u2019s Disease Decline While Glucose Hypometabolism Drives Late Decline. Commun. Biol., 3.","DOI":"10.1038\/s42003-020-1079-x"},{"key":"ref_44","first-page":"773","article-title":"Deciphering an Interplay of Proteins Associated with Amyloid \u03b2 1-42 Peptide and Molecular Mechanisms of Alzheimer\u2019s Disease","volume":"25","year":"2014","journal-title":"Rev. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Sehar, U., Rawat, P., Reddy, A.P., Kopel, J., and Reddy, P.H. (2022). Amyloid Beta in Aging and Alzheimer\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112924"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"105208","DOI":"10.1016\/j.neuint.2021.105208","article-title":"Aggregation and Structure of Amyloid \u03b2-Protein","volume":"151","author":"Ono","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"fcab147","DOI":"10.1093\/braincomms\/fcab147","article-title":"Soluble Amyloid Beta-Containing Aggregates Are Present throughout the Brain at Early Stages of Alzheimer\u2019s Disease","volume":"3","author":"Sideris","year":"2021","journal-title":"Brain Commun."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Yang, Y.-H., Huang, L.-C., Hsieh, S.-W., and Huang, L.-J. (2020). Dynamic Blood Concentrations of A\u03b21-40 and A\u03b21-42 in Alzheimer\u2019s Disease. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00768"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1111\/j.1753-4887.2012.00505.x","article-title":"Role of the Intestinal Microbiome in Health and Disease: From Correlation to Causation","volume":"70","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What Is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","article-title":"Gut Microbiota and Dysbiosis in Alzheimer\u2019s Disease: Implications for Pathogenesis and Treatment","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota-Gut-Brain Axis and Its Therapeutic Applications in Neurodegenerative Diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_53","first-page":"203","article-title":"The Gut-Brain Axis: Interactions between Enteric Microbiota, Central and Enteric Nervous Systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chen, Y., Xu, J., and Chen, Y. (2021). Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients, 13.","DOI":"10.3390\/nu13062099"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"G\u00f3ralczyk-Bi\u0144kowska, A., Szmajda-Krygier, D., and Koz\u0142owska, E. (2022). The Microbiota-Gut-Brain Axis in Psychiatric Disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911245"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Vagnerov\u00e1, K., Vodi\u010dka, M., Hermanov\u00e1, P., Ergang, P., \u0160r\u016ftkov\u00e1, D., Kluso\u0148ov\u00e1, P., Balounov\u00e1, K., Hudcovic, T., and P\u00e1cha, J. (2019). Interactions Between Gut Microbiota and Acute Restraint Stress in Peripheral Structures of the Hypothalamic-Pituitary-Adrenal Axis and the Intestine of Male Mice. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02655"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.coph.2012.09.010","article-title":"Communication between Gastrointestinal Bacteria and the Nervous System","volume":"12","author":"Bravo","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/arclin\/acac008","article-title":"The Microbiota-Gut-Brain Axis in Alzheimer\u2019s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions","volume":"37","author":"Murray","year":"2022","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, Z.-L., Ma, H.-T., Wang, M., and Qian, Y.-H. (2022). Research Trend of Microbiota-Gut-Brain Axis in Alzheimer\u2019s Disease Based on CiteSpace (2012\u20132021): A Bibliometrics Analysis of 608 Articles. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.1036120"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in Health and Diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Al Bataineh, M.T., K\u00fcnstner, A., Dash, N.R., Alsafar, H.S., Ragab, M., Schmelter, F., Sina, C., Busch, H., and Ibrahim, S.M. (2023). Uncovering the Relationship between Gut Microbial Dysbiosis, Metabolomics, and Dietary Intake in Type 2 Diabetes Mellitus and in Healthy Volunteers: A Multi-Omics Analysis. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-45066-7"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"eaba0466","DOI":"10.1126\/sciadv.aba0466","article-title":"Gut Dysbiosis Contributes to Amyloid Pathology, Associated with C\/EBP\u03b2\/AEP Signaling Activation in Alzheimer\u2019s Disease Mouse Model","volume":"6","author":"Chen","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., Harding, S.J., Merluzzi, A.P., Johnson, S.C., Carlsson, C.M., Asthana, S., Zetterberg, H., and Blennow, K. (2017). Gut Microbiome Alterations in Alzheimer\u2019s Disease. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-13601-y"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"O\u2019Callaghan, A., and van Sinderen, D. (2016). Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00925"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.chom.2022.07.003","article-title":"Butyrate-Producing Eubacterium Rectale Suppresses Lymphomagenesis by Alleviating the TNF-Induced TLR4\/MyD88\/NF-\u03baB Axis","volume":"30","author":"Lu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.18632\/aging.203826","article-title":"Gut Microbiota in Patients with Alzheimer\u2019s Disease Spectrum: A Systematic Review and Meta-Analysis","volume":"14","author":"Hung","year":"2022","journal-title":"Aging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","article-title":"Porphyromonas Gingivalis in Alzheimer\u2019s Disease Brains: Evidence for Disease Causation and Treatment with Small-Molecule Inhibitors","volume":"5","author":"Dominy","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Leblhuber, F., Ehrlich, D., Steiner, K., Geisler, S., Fuchs, D., Lanser, L., and Kurz, K. (2021). The Immunopathogenesis of Alzheimer\u2019s Disease Is Related to the Composition of Gut Microbiota. Nutrients, 13.","DOI":"10.3390\/nu13020361"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Eicher, T.P., and Mohajeri, M.H. (2022). Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases. Nutrients, 14.","DOI":"10.3390\/nu14132661"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Giau, V.V., Wu, S.Y., Jamerlan, A., An, S.S.A., Kim, S.Y., and Hulme, J. (2018). Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer\u2019s Disease. Nutrients, 10.","DOI":"10.3390\/nu10111765"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Dissanayaka, D.M.S., Jayasena, V., Rainey-Smith, S.R., Martins, R.N., and Fernando, W.M.A.D.B. (2024). The Role of Diet and Gut Microbiota in Alzheimer\u2019s Disease. Nutrients, 16.","DOI":"10.3390\/nu16030412"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.mayocp.2016.04.024","article-title":"Physical Activity and Alzheimer Disease: A Protective Association","volume":"91","author":"Emanuele","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/s41380-023-02076-1","article-title":"Step by Step: Towards a Better Understanding of the Genetic Architecture of Alzheimer\u2019s Disease","volume":"28","author":"Lambert","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","article-title":"Genetics of Alzheimer\u2019s Disease: Where We Are, and Where We Are Going","volume":"61","author":"Bellenguez","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a Missense Mutation in the Amyloid Precursor Protein Gene with Familial Alzheimer\u2019s Disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Liu, Y., Xiao, X., Liu, H., Liao, X., Zhou, Y., Weng, L., Zhou, L., Liu, X., Bi, X.-Y., and Xu, T. (2022). Clinical Characteristics and Genotype-Phenotype Correlation Analysis of Familial Alzheimer\u2019s Disease Patients with Pathogenic\/Likely Pathogenic Amyloid Protein Precursor Mutations. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.1013295"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Barber, I.S., Garc\u00eda-C\u00e1rdenas, J.M., Sakdapanichkul, C., Deacon, C., Zapata Erazo, G., Guerreiro, R., Bras, J., Hernandez, D., Singleton, A., and Guetta-Baranes, T. (2016). Screening Exons 16 and 17 of the Amyloid Precursor Protein Gene in Sporadic Early-Onset Alzheimer\u2019s Disease. Neurobiol. Aging, 39.","DOI":"10.1016\/j.neurobiolaging.2015.12.011"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4103\/1673-5374.247469","article-title":"Mutations of Beta-Amyloid Precursor Protein Alter the Consequence of Alzheimer\u2019s Disease Pathogenesis","volume":"14","author":"Li","year":"2019","journal-title":"Neural Regen. Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Lanoisel\u00e9e, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A., and Martinaud, O. (2017). APP, PSEN1, and PSEN2 Mutations in Early-Onset Alzheimer Disease: A Genetic Screening Study of Familial and Sporadic Cases. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002270"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/brain\/awac294","article-title":"Aberrant Splicing of PSEN2, but Not PSEN1, in Individuals with Sporadic Alzheimer\u2019s Disease","volume":"146","author":"Course","year":"2023","journal-title":"Brain"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12640-020-00232-x","article-title":"Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer\u2019s Disease","volume":"38","author":"Kabir","year":"2020","journal-title":"Neurotox. Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Bagaria, J., Bagyinszky, E., and An, S.S.A. (2022). Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810970"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Do, H.N., Devkota, S., Bhattarai, A., Wolfe, M.S., and Miao, Y. (2023). Effects of Presenilin-1 Familial Alzheimer\u2019s Disease Mutations on \u03b3-Secretase Activation for Cleavage of Amyloid Precursor Protein. Commun. Biol., 6.","DOI":"10.1038\/s42003-023-04539-1"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/1673-5374.313016","article-title":"Presenilin Mutations and Their Impact on Neuronal Differentiation in Alzheimer\u2019s Disease","volume":"17","author":"Cevallos","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1038\/s41380-022-01518-6","article-title":"A\u03b2 Profiles Generated by Alzheimer\u2019s Disease Causing PSEN1 Variants Determine the Pathogenicity of the Mutation and Predict Age at Disease Onset","volume":"27","author":"Petit","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Flowers, S.A., and Rebeck, G.W. (2020). APOE in the Normal Brain. Neurobiol. Dis., 136.","DOI":"10.1016\/j.nbd.2019.104724"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s Disease: Pathophysiology and Therapeutic Strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Husain, M.A., Laurent, B., and Plourde, M. (2021). APOE and Alzheimer\u2019s Disease: From Lipid Transport to Physiopathology and Therapeutics. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.630502"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Yassine, H.N., and Finch, C.E. (2020). APOE Alleles and Diet in Brain Aging and Alzheimer\u2019s Disease. Front. Aging Neurosci., 12.","DOI":"10.3389\/fnagi.2020.00150"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ddr.21643","article-title":"Insulin Resistance and Impaired Lipid Metabolism as a Potential Link between Diabetes and Alzheimer\u2019s Disease","volume":"81","author":"Kulas","year":"2020","journal-title":"Drug Dev. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","article-title":"APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry","volume":"80","author":"Belloy","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer Disease: Pathobiology and Targeting Strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Giraldo, M., Gonz\u00e1lez-Reyes, R.E., Ram\u00edrez-Guerrero, S., Bonilla-Trilleras, C.E., Guardo-Maya, S., and Nava-Mesa, M.O. (2022). Astrocytes as a Therapeutic Target in Alzheimer\u2019s Disease-Comprehensive Review and Recent Developments. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113630"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Nguyen, T.T., Ta, Q.T.H., Nguyen, T.K.O., Nguyen, T.T.D., and Giau, V.V. (2020). Type 3 Diabetes and Its Role Implications in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093165"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Athanasaki, A., Melanis, K., Tsantzali, I., Stefanou, M.I., Ntymenou, S., Paraskevas, S.G., Kalamatianos, T., Boutati, E., Lambadiari, V., and Voumvourakis, K.I. (2022). Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer\u2019s Disease: Review and Meta-Analysis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040778"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.sjbs.2019.12.028","article-title":"Diabetes as a Risk Factor for Alzheimer\u2019s Disease in the Middle East and Its Shared Pathological Mediators","volume":"27","author":"Jayaraj","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e73138","DOI":"10.7554\/eLife.73138","article-title":"Type 2 Diabetes Mellitus Accelerates Brain Aging and Cognitive Decline: Complementary Findings from UK Biobank and Meta-Analyses","volume":"11","author":"Antal","year":"2022","journal-title":"eLife"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife Type 2 Diabetes and Poor Glycaemic Control as Risk Factors for Cognitive Decline in Early Old Age: A Post-Hoc Analysis of the Whitehall II Cohort Study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin Action in Brain Regulates Systemic Metabolism and Brain Function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative Stress, Dysfunctional Glucose Metabolism and Alzheimer Disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1464-5491.2011.03464.x","article-title":"Insulin Resistance and Pathological Brain Ageing","volume":"28","author":"Cholerton","year":"2011","journal-title":"Diabet. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.12.001","article-title":"Insulin-Mediated Synaptic Plasticity in the CNS: Anatomical, Functional and Temporal Contexts","volume":"136","author":"Ferrario","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Cimini, F.A., Perluigi, M., Barchetta, I., Cavallo, M.G., and Barone, E. (2022). Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105574"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1038\/ncomms15259","article-title":"Neuronal Control of Peripheral Insulin Sensitivity and Glucose Metabolism","volume":"8","author":"Ruud","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Spinelli, M., Fusco, S., and Grassi, C. (2019). Brain Insulin Resistance and Hippocampal Plasticity: Mechanisms and Biomarkers of Cognitive Decline. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00788"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the Brain: There and Back Again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Wang, Z., Tang, X., Swaminathan, S.K., Kandimalla, K.K., and Kalari, K.R. (2022). Mapping the Dynamics of Insulin-Responsive Pathways in the Blood-Brain Barrier Endothelium Using Time-Series Transcriptomics Data. NPJ Syst. Biol. Appl., 8.","DOI":"10.1038\/s41540-022-00235-8"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20160493","article-title":"Changes in Insulin and Insulin Signaling in Alzheimer\u2019s Disease: Cause or Consequence?","volume":"213","author":"Stanley","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/awac309","article-title":"Cerebrovascular Insulin Receptors Are Defective in Alzheimer\u2019s Disease","volume":"146","author":"Leclerc","year":"2023","journal-title":"Brain"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","article-title":"Glucose Transporters in Brain in Health and Disease","volume":"472","author":"Koepsell","year":"2020","journal-title":"Pflug. Arch."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41366-024-01490-x","article-title":"The Mitochondrial Quality Control System: A New Target for Exercise Therapeutic Intervention in the Treatment of Brain Insulin Resistance-Induced Neurodegeneration in Obesity","volume":"48","author":"Cai","year":"2024","journal-title":"Int. J. Obes."},{"key":"ref_112","first-page":"1688","article-title":"State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer\u2019s Disease","volume":"15","author":"Rhea","year":"2024","journal-title":"Aging Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/jnr.21787","article-title":"Defective Insulin Signaling Pathway and Increased Glycogen Synthase Kinase-3 Activity in the Brain of Diabetic Mice: Parallels with Alzheimer\u2019s Disease and Correction by Insulin","volume":"86","author":"Jolivalt","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"ref_114","first-page":"321280","article-title":"Insulin Receptor Expression and Activity in the Brains of Nondiabetic Sporadic Alzheimer\u2019s Disease Cases","volume":"2012","author":"Ho","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer\u2019s Disease from Perturbed Cerebral Glucose Metabolism: Implications for Diagnostic and Therapeutic Strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.13031","article-title":"Vitamin B1 (Thiamine) and Dementia","volume":"1367","author":"Gibson","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"34472","DOI":"10.1074\/jbc.R114.601351","article-title":"The Emerging Link between O-GlcNAc and Alzheimer Disease","volume":"289","author":"Zhu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"S\u0119dzikowska, A., and Szablewski, L. (2021). Insulin and Insulin Resistance in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189987"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wei, Z., Koya, J., and Reznik, S.E. (2021). Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.687157"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain Insulin Resistance in Type 2 Diabetes and Alzheimer Disease: Concepts and Conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Berlanga-Acosta, J., Guill\u00e9n-Nieto, G., Rodr\u00edguez-Rodr\u00edguez, N., Bringas-Vega, M.L., Garc\u00eda-Del-Barco-Herrera, D., Berlanga-Saez, J.O., Garc\u00eda-Ojalvo, A., Vald\u00e9s-Sosa, M.J., and Vald\u00e9s-Sosa, P.A. (2020). Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.560375"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Ball, B.K., Kuhn, M.K., Fleeman Bechtel, R.M., Proctor, E.A., and Brubaker, D.K. (2024). Differential Responses of Primary Neuron-Secreted MCP-1 and IL-9 to Type 2 Diabetes and Alzheimer\u2019s Disease-Associated Metabolites. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-62155-3"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.2912","article-title":"Deficient Brain Insulin Signalling Pathway in Alzheimer\u2019s Disease and Diabetes","volume":"225","author":"Liu","year":"2011","journal-title":"J. Pathol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An Updated Meta-Analysis of Cohort Studies: Diabetes and Risk of Alzheimer\u2019s Disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","article-title":"Mechanisms of Amyloid-\u03b2 Peptide Clearance: Potential Therapeutic Targets for Alzheimer\u2019s Disease","volume":"20","author":"Yoon","year":"2012","journal-title":"Biomol. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Wang, D., Chen, F., Han, Z., Yin, Z., Ge, X., and Lei, P. (2021). Relationship Between Amyloid-\u03b2 Deposition and Blood-Brain Barrier Dysfunction in Alzheimer\u2019s Disease. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.695479"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"101999","DOI":"10.1016\/j.arr.2023.101999","article-title":"Insulin-Degrading Enzyme: Roles and Pathways in Ameliorating Cognitive Impairment Associated with Alzheimer\u2019s Disease and Diabetes","volume":"90","author":"Tian","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"102119","DOI":"10.1016\/j.arr.2023.102119","article-title":"Evaluation and Targeting of Amyloid Precursor Protein (APP)\/Amyloid Beta (A\u03b2) Axis in Amyloidogenic and Non-Amyloidogenic Pathways: A Time Outside the Tunnel","volume":"92","author":"Jabir","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer\u2019s Disease a Type 3 Diabetes? A Critical Appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","article-title":"The PI3K\/Akt Signaling Axis in Alzheimer\u2019s Disease: A Valuable Target to Stimulate or Suppress?","volume":"26","author":"Razani","year":"2021","journal-title":"Cell Stress. Chaperones"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","article-title":"Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer\u2019s Disease","volume":"59","author":"Kumar","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Gabbouj, S., Ryh\u00e4nen, S., Marttinen, M., Wittrahm, R., Takalo, M., Kemppainen, S., Martiskainen, H., Tanila, H., Haapasalo, A., and Hiltunen, M. (2019). Altered Insulin Signaling in Alzheimer\u2019s Disease Brain\u2014Special Emphasis on PI3K-Akt Pathway. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00629"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","article-title":"Diabetes Mellitus and Alzheimer\u2019s Disease: GSK-3\u03b2 as a Potential Link","volume":"339","author":"Zhang","year":"2018","journal-title":"Behav. Brain Res."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Hamz\u00e9, R., Delangre, E., Tolu, S., Moreau, M., Janel, N., Bailb\u00e9, D., and Movassat, J. (2022). Type 2 Diabetes Mellitus and Alzheimer\u2019s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315287"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2022.12.016","article-title":"Insulin Resistance in Alzheimer\u2019s Disease: The Genetics and Metabolomics Links","volume":"539","author":"Amin","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Burillo, J., Marqu\u00e9s, P., Jim\u00e9nez, B., Gonz\u00e1lez-Blanco, C., Benito, M., and Guill\u00e9n, C. (2021). Insulin Resistance and Diabetes Mellitus in Alzheimer\u2019s Disease. Cells, 10.","DOI":"10.3390\/cells10051236"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"A\u03b2 Amyloid Pathology Affects the Hearts of Patients With Alzheimer\u2019s Disease: Mind the Heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Kauwe, G., and Tracy, T.E. (2021). Amyloid Beta Emerges from below the Neck to Disable the Brain. PLoS Biol., 19.","DOI":"10.1371\/journal.pbio.3001388"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10787-023-01202-3","article-title":"Hepatic and Cardiac Implications of Increased Toxic Amyloid-Beta Serum Level in Lipopolysaccharide-Induced Neuroinflammation in Rats: New Insights into Alleviating Therapeutic Interventions","volume":"31","author":"Anwar","year":"2023","journal-title":"Inflammopharmacology"},{"key":"ref_140","first-page":"5409","article-title":"Amyloid-\u03b2 and Islet Amyloid Pathologies Link Alzheimer\u2019s Disease and Type 2 Diabetes in a Transgenic Model","volume":"31","author":"Wijesekara","year":"2017","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mp.2016.230","article-title":"Molecular Interaction between Type 2 Diabetes and Alzheimer\u2019s Disease through Cross-Seeding of Protein Misfolding","volume":"22","author":"Salvadores","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13024-022-00518-y","article-title":"Islet Amyloid Polypeptide Cross-Seeds Tau and Drives the Neurofibrillary Pathology in Alzheimer\u2019s Disease","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Duarte, A.I., Candeias, E., Alves, I.N., Mena, D., Silva, D.F., Machado, N.J., Campos, E.J., Santos, M.S., Oliveira, C.R., and Moreira, P.I. (2020). Liraglutide Protects Against Brain Amyloid-\u03921-42 Accumulation in Female Mice with Early Alzheimer\u2019s Disease-Like Pathology by Partially Rescuing Oxidative\/Nitrosative Stress and Inflammation. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051746"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Carranza-Naval, M.J., Del Marco, A., Hierro-Bujalance, C., Alves-Martinez, P., Infante-Garcia, C., Vargas-Soria, M., Herrera, M., Barba-Cordoba, B., Atienza-Navarro, I., and Lubian-Lopez, S. (2021). Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer\u2019s Disease and Type 2 Diabetes. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.741923"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2019.01.103","article-title":"Dulaglutide Ameliorates STZ Induced AD-like Impairment of Learning and Memory Ability by Modulating Hyperphosphorylation of Tau and NFs through GSK3\u03b2","volume":"511","author":"Zhou","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2017.11.114","article-title":"Lixisenatide Reduces Amyloid Plaques, Neurofibrillary Tangles and Neuroinflammation in an APP\/PS1\/Tau Mouse Model of Alzheimer\u2019s Disease","volume":"495","author":"Cai","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of Dulaglutide on Cognitive Impairment in Type 2 Diabetes: An Exploratory Analysis of the REWIND Trial","volume":"19","author":"Gerstein","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Kellar, D., Register, T., Lockhart, S.N., Aisen, P., Raman, R., Rissman, R.A., Brewer, J., and Craft, S. (2022). Intranasal Insulin Modulates Cerebrospinal Fluid Markers of Neuroinflammation in Mild Cognitive Impairment and Alzheimer\u2019s Disease: A Randomized Trial. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-05165-3"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment: A Pilot Clinical Trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0271678X17709709","article-title":"Insulin Differentially Affects the Distribution Kinetics of Amyloid Beta 40 and 42 in Plasma and Brain","volume":"38","author":"Swaminathan","year":"2018","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"352723","DOI":"10.1155\/2015\/352723","article-title":"The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer\u2019s Disease","volume":"2015","author":"Liu","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J., and Reddy, P.H. (2022). Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112841"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e01577","DOI":"10.1002\/brb3.1577","article-title":"Neurodegeneration in Type 2 Diabetes: Alzheimer\u2019s as a Case Study","volume":"10","author":"Madhusudhanan","year":"2020","journal-title":"Brain Behav."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41419-023-05909-7","article-title":"High Glucose Induces Tau Hyperphosphorylation in Hippocampal Neurons via Inhibition of ALKBH5-Mediated Dgkh m6A Demethylation: A Potential Mechanism for Diabetic Cognitive Dysfunction","volume":"14","author":"Qu","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1523\/JNEUROSCI.5561-03.2004","article-title":"Alterations in Glucose Metabolism Induce Hypothermia Leading to Tau Hyperphosphorylation through Differential Inhibition of Kinase and Phosphatase Activities: Implications for Alzheimer\u2019s Disease","volume":"24","author":"Planel","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Sato, N., and Morishita, R. (2015). The Roles of Lipid and Glucose Metabolism in Modulation of \u03b2-Amyloid, Tau, and Neurodegeneration in the Pathogenesis of Alzheimer Disease. Front. Aging Neurosci., 7.","DOI":"10.3389\/fnagi.2015.00199"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer\u2019s Disease Neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1152\/physrev.00006.2023","article-title":"Lung Endothelium, Tau, and Amyloids in Health and Disease","volume":"104","author":"Balczon","year":"2024","journal-title":"Physiol. Rev."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41392-023-01701-3","article-title":"Tau in the Pancreas: Understanding the Link between Type 2 Diabetes Mellitus and Alzheimer\u2019s Disease","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1096\/fj.201900322R","article-title":"Infection-Induced Endothelial Amyloids Impair Memory","volume":"33","author":"Balczon","year":"2019","journal-title":"FASEB J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1164\/rccm.201801-0060LE","article-title":"Nosocomial Pneumonia Elicits an Endothelial Proteinopathy: Evidence for a Source of Neurotoxic Amyloids in Critically Ill Patients","volume":"198","author":"Lin","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Scott, A.M., Jager, A.C., Gwin, M., Voth, S., Balczon, R., Stevens, T., and Lin, M.T. (2020). Pneumonia-Induced Endothelial Amyloids Reduce Dendritic Spine Density in Brain Neurons. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-66321-1"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1038\/s41380-023-02267-w","article-title":"Tau Suppresses Microtubule-Regulated Pancreatic Insulin Secretion","volume":"28","author":"Mangiafico","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1111\/ene.15039","article-title":"Diabetes Mellitus Contributes to Higher Cerebrospinal Fluid Tau Levels Selectively in Alzheimer\u2019s Disease Patients with the APOE4 Genotype","volume":"28","author":"Motta","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_165","first-page":"138","article-title":"High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer\u2019s Disease Via a Specific Tau Phosphorylation Pattern","volume":"11","author":"Ito","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Lu, Y., Jiang, X., Liu, S., and Li, M. (2018). Changes in Cerebrospinal Fluid Tau and \u03b2-Amyloid Levels in Diabetic and Prediabetic Patients: A Meta-Analysis. Front. Aging Neurosci., 10.","DOI":"10.3389\/fnagi.2018.00271"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., and Mudher, A. (2018). Alzheimer\u2019s Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00383"},{"key":"ref_168","unstructured":"Chung, Y., and Lee, H. (2021). the Alzheimer\u2019s Disease Neuroimaging Initiative Correlation between Alzheimer\u2019s Disease and Type 2 Diabetes Using Non-Negative Matrix Factorization. Sci. Rep., 11."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e12202","DOI":"10.1016\/j.heliyon.2022.e12202","article-title":"Revealing Genetic Links of Type 2 Diabetes That Lead to the Development of Alzheimer\u2019s Disease","volume":"9","author":"Afzal","year":"2023","journal-title":"Heliyon"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jns.2017.07.044","article-title":"Linking Alzheimer\u2019s Disease and Type 2 Diabetes: Novel Shared Susceptibility Genes Detected by cFDR Approach","volume":"380","author":"Wang","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"6435861","DOI":"10.1155\/2018\/6435861","article-title":"Oxidant\/Antioxidant Imbalance in Alzheimer\u2019s Disease: Therapeutic and Diagnostic Prospects","volume":"2018","author":"Wojsiat","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/emm.2013.147","article-title":"Increased Expression of the Receptor for Advanced Glycation End Products in Neurons and Astrocytes in a Triple Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"46","author":"Choi","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Veselov, I.M., Vinogradova, D.V., Maltsev, A.V., Shevtsov, P.N., Spirkova, E.A., Bachurin, S.O., and Shevtsova, E.F. (2023). Mitochondria and Oxidative Stress as a Link between Alzheimer\u2019s Disease and Diabetes Mellitus. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914450"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41401-019-0239-3","article-title":"Interplay between Alzheimer\u2019s Disease and Global Glucose Metabolism Revealed by the Metabolic Profile Alterations of Pancreatic Tissue and Serum in APP\/PS1 Transgenic Mice","volume":"40","author":"Liu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-009-0517-0","article-title":"Oxidatively Modified Proteins in Alzheimer\u2019s Disease (AD), Mild Cognitive Impairment and Animal Models of AD: Role of Abeta in Pathogenesis","volume":"118","author":"Sultana","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12655","article-title":"Alzheimer\u2019s Disease and Type 2 Diabetes Mellitus Are Distinct Diseases with Potential Overlapping Metabolic Dysfunction Upstream of Observed Cognitive Decline","volume":"29","author":"Chornenkyy","year":"2019","journal-title":"Brain Pathol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Chandrasekaran, P., and Weiskirchen, R. (2024). The Role of Obesity in Type 2 Diabetes Mellitus-An Overview. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031882"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-020-05140-5","article-title":"Obesity, Unfavourable Lifestyle and Genetic Risk of Type 2 Diabetes: A Case-Cohort Study","volume":"63","author":"Schnurr","year":"2020","journal-title":"Diabetologia"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Flores-Cordero, J.A., P\u00e9rez-P\u00e9rez, A., Jim\u00e9nez-Cortegana, C., Alba, G., Flores-Barrag\u00e1n, A., and S\u00e1nchez-Margalet, V. (2022). Obesity as a Risk Factor for Dementia and Alzheimer\u2019s Disease: The Role of Leptin. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095202"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Lloret, A., Monllor, P., Esteve, D., Cervera-Ferri, A., and Lloret, M.-A. (2019). Obesity as a Risk Factor for Alzheimer\u2019s Disease: Implication of Leptin and Glutamate. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00508"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3233\/JAD-220535","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer\u2019s Disease in an Observational Cohort Study","volume":"91","author":"Morys","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Cho, S.H., Jang, M., Ju, H., Kang, M.J., Yun, J.M., and Yun, J.W. (2022). Association of Late-Life Body Mass Index with the Risk of Alzheimer Disease: A 10-Year Nationwide Population-Based Cohort Study. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-19696-2"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"34691","DOI":"10.18632\/oncotarget.26162","article-title":"Obesity and Alzheimer\u2019s Disease, Does the Obesity Paradox Really Exist? A Magnetic Resonance Imaging Study","volume":"9","author":"Pegueroles","year":"2018","journal-title":"Oncotarget"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11906-022-01221-5","article-title":"Effects of Hypertension on Alzheimer\u2019s Disease and Related Disorders","volume":"24","author":"Malone","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Yamada, T., Kimura-Koyanagi, M., Sakaguchi, K., Ogawa, W., and Tamori, Y. (2023). Obesity and Risk for Its Comorbidities Diabetes, Hypertension, and Dyslipidemia in Japanese Individuals Aged 65 Years. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-29276-7"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YCO.0000000000000684","article-title":"Hypertension and Alzheimer\u2019s Disease: Is the Picture Any Clearer?","volume":"34","author":"Lennon","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41440-022-01014-y","article-title":"Pathogenic Connection between Hypertension and Type 2 Diabetes: How Do They Mutually Affect Each Other?","volume":"45","author":"Tanaka","year":"2022","journal-title":"Hypertens. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"e050335","DOI":"10.1136\/bmjopen-2021-050335","article-title":"Intensive versus Standard Blood Pressure Control in Type 2 Diabetes: A Restricted Mean Survival Time Analysis of a Randomised Controlled Trial","volume":"11","author":"Shi","year":"2021","journal-title":"BMJ Open"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Canavan, M., and O\u2019Donnell, M.J. (2022). Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.821135"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","article-title":"Hypertension-Induced Cognitive Impairment: From Pathophysiology to Public Health","volume":"17","author":"Ungvari","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-190474","article-title":"Midlife Hypertension and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"71","author":"Lennon","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"fcaa114","DOI":"10.1093\/braincomms\/fcaa114","article-title":"Hypertension and Alzheimer\u2019s Disease: Indirect Effects through Circle of Willis Atherosclerosis","volume":"2","author":"Eglit","year":"2020","journal-title":"Brain Commun."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-017-0262-x","article-title":"Association between Blood Pressure and Alzheimer Disease Measured up to 27 Years Prior to Diagnosis: The HUNT Study","volume":"9","author":"Gabin","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.121.17283","article-title":"Blood Pressure Levels and Risks of Dementia: A Nationwide Study of 4.5 Million People","volume":"79","author":"Lee","year":"2022","journal-title":"Hypertension"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e209715","DOI":"10.1212\/WNL.0000000000209715","article-title":"Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk: An Individual Participant Data Meta-Analysis","volume":"103","author":"Lennon","year":"2024","journal-title":"Neurology"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Li, Z., Li, S., Xiao, Y., Zhong, T., Yu, X., and Wang, L. (2022). Nutritional Intervention for Diabetes Mellitus with Alzheimer\u2019s Disease. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1046726"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-018-1018-0","article-title":"Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies","volume":"18","author":"Silbert","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"ref_198","first-page":"2702","article-title":"Effect of Different Blood Glucose Intervention Plans on Elderly People with Type 2 Diabetes Mellitus Combined with Dementia","volume":"21","author":"Chen","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e3188","DOI":"10.1002\/dmrr.3188","article-title":"The Effects of Popular Diets on Type 2 Diabetes Management","volume":"35","author":"Chester","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10654-017-0352-x","article-title":"A Network Meta-Analysis on the Comparative Efficacy of Different Dietary Approaches on Glycaemic Control in Patients with Type 2 Diabetes Mellitus","volume":"33","author":"Schwingshackl","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/10408398.2019.1565281","article-title":"Mediterranean Diet, Cardiovascular Disease and Mortality in Diabetes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies and Randomized Clinical Trials","volume":"60","author":"Viguiliouk","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/dc19-0130","article-title":"The Mediterranean Diet and 2-Year Change in Cognitive Function by Status of Type 2 Diabetes and Glycemic Control","volume":"42","author":"Mattei","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/nyas.13047","article-title":"Nutrition and Risk of Dementia: Overview and Methodological Issues","volume":"1367","author":"Morris","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jalz.2014.11.009","article-title":"MIND Diet Associated with Reduced Incidence of Alzheimer\u2019s Disease","volume":"11","author":"Morris","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3945\/ajcn.112.051276","article-title":"Prospective Study of Dietary Approaches to Stop Hypertension- and Mediterranean-Style Dietary Patterns and Age-Related Cognitive Change: The Cache County Study on Memory, Health and Aging","volume":"98","author":"Wengreen","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","article-title":"The Therapeutic Implications of Ketone Bodies: The Effects of Ketone Bodies in Pathological Conditions: Ketosis, Ketogenic Diet, Redox States, Insulin Resistance, and Mitochondrial Metabolism","volume":"70","author":"Veech","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_207","first-page":"e9639","article-title":"Advantages and Disadvantages of the Ketogenic Diet: A Review Article","volume":"12","author":"Batch","year":"2020","journal-title":"Cureus"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Takeishi, J., Tatewaki, Y., Nakase, T., Takano, Y., Tomita, N., Yamamoto, S., Mutoh, T., and Taki, Y. (2021). Alzheimer\u2019s Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212310"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Abboud, M., AlAnouti, F., Georgaki, E., and Papandreou, D. (2021). Effect of Ketogenic Diet on Quality of Life in Adults with Chronic Disease: A Systematic Review of Randomized Controlled Trials. Nutrients, 13.","DOI":"10.3390\/nu13124463"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11892-021-01399-z","article-title":"Efficacy of Ketogenic Diets on Type 2 Diabetes: A Systematic Review","volume":"21","author":"Tinguely","year":"2021","journal-title":"Curr. Diab Rep."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"102905","DOI":"10.1016\/j.dsx.2023.102905","article-title":"The Effects of the Ketogenic Diet for the Management of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Recent Studies","volume":"17","author":"Choy","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Brownlow, M.L., Benner, L., D\u2019Agostino, D., Gordon, M.N., and Morgan, D. (2013). Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer\u2019s Pathology. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075713"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/cns.13779","article-title":"Ketogenic Diet Ameliorates Cognitive Impairment and Neuroinflammation in a Mouse Model of Alzheimer\u2019s Disease","volume":"28","author":"Xu","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.expneurol.2011.09.001","article-title":"Ketogenic Diet-Induced Peroxisome Proliferator-Activated Receptor-\u03b3 Activation Decreases Neuroinflammation in the Mouse Hippocampus after Kainic Acid-Induced Seizures","volume":"232","author":"Jeong","year":"2011","journal-title":"Exp. Neurol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.brainres.2016.06.029","article-title":"Ketogenic Diet Attenuates Spatial and Item Memory Impairment in Pentylenetetrazol-Kindled Rats","volume":"1646","author":"Jiang","year":"2016","journal-title":"Brain Res."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"106454","DOI":"10.1016\/j.eplepsyres.2020.106454","article-title":"Ketogenic Diet and Neuroinflammation","volume":"167","author":"Koh","year":"2020","journal-title":"Epilepsy Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1039\/C9FO01062A","article-title":"Lactobacillus Acidophilus Alleviates Type 2 Diabetes by Regulating Hepatic Glucose, Lipid Metabolism and Gut Microbiota in Mice","volume":"10","author":"Yan","year":"2019","journal-title":"Food Funct."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.freeradbiomed.2022.12.003","article-title":"Vitamin C Supplementation for Diabetes Management: A Comprehensive Narrative Review","volume":"194","author":"Mason","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Hamid, M., Mansoor, S., Amber, S., and Zahid, S. (2022). A Quantitative Meta-Analysis of Vitamin C in the Pathophysiology of Alzheimer\u2019s Disease. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.970263"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1060028016673072","article-title":"Use of Vitamin E and C Supplements for the Prevention of Cognitive Decline","volume":"51","author":"Basambombo","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1152\/japplphysiol.00866.2021","article-title":"Insulin Blood-Brain Barrier Transport and Interactions Are Greater Following Exercise in Mice","volume":"132","author":"Brown","year":"2022","journal-title":"J. Appl. Physiol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11011-022-00903-y","article-title":"Regulation of microRNAs in Alzheimer\u2019s Disease, Type 2 Diabetes, and Aerobic Exercise Training","volume":"37","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2337\/dc21-1597","article-title":"Changes in Physical Activity and the Risk of Dementia in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study","volume":"45","author":"Yoo","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Ghahfarrokhi, M.M., Shirvani, H., Rahimi, M., Bazgir, B., Shamsadini, A., and Sobhani, V. (2024). Feasibility and Preliminary Efficacy of Different Intensities of Functional Training in Elderly Type 2 Diabetes Patients with Cognitive Impairment: A Pilot Randomised Controlled Trial. BMC Geriatr., 24.","DOI":"10.1186\/s12877-024-04698-8"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/hmbci-2022-0061","article-title":"The Effects of Endurance Exercise and Metformin on Memory Impairment Caused by Diabetes","volume":"44","author":"Shabab","year":"2023","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-220389","article-title":"Associations of Physical Activity with Alzheimer\u2019s Disease Pathologies and Cognition: The CABLE Study","volume":"89","author":"Zhong","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00415-022-11454-8","article-title":"Effects of Physical Activity and Exercise Interventions on Alzheimer\u2019s Disease: An Umbrella Review of Existing Meta-Analyses","volume":"270","author":"Lista","year":"2023","journal-title":"J. Neurol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.300.9.1027","article-title":"Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease: A Randomized Trial","volume":"300","author":"Lautenschlager","year":"2008","journal-title":"JAMA"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Zhong, G., Wang, Y., Zhang, Y., Guo, J.J., and Zhao, Y. (2015). Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118333"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11892-017-0903-2","article-title":"Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action","volume":"17","author":"Zhu","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3233\/JAD-220647","article-title":"Impact of Cigarette Smoking and Its Interaction with Hypertension and Diabetes on Cognitive Function in Older Americans","volume":"90","author":"Restifo","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.jalz.2014.04.009","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative Smoking and Increased Alzheimer\u2019s Disease Risk: A Review of Potential Mechanisms","volume":"10","author":"Durazzo","year":"2014","journal-title":"Alzheimers Dement."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Benito-Le\u00f3n, J., Ghosh, R., Lape\u00f1a-Motilva, J., Mart\u00edn-Arriscado, C., and Bermejo-Pareja, F. (2023). Association between Cumulative Smoking Exposure and Cognitive Decline in Non-Demented Older Adults: NEDICES Study. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-32663-9"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/aje\/kwm116","article-title":"Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies","volume":"166","author":"Anstey","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Ohkuma, T., Iwase, M., Fujii, H., Kaizu, S., Ide, H., Jodai, T., Kikuchi, Y., Idewaki, Y., Hirakawa, Y., and Nakamura, U. (2015). Dose- and Time-Dependent Association of Smoking and Its Cessation with Glycemic Control and Insulin Resistance in Male Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122023"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Norouzzadeh, M., Teymoori, F., Farhadnejad, H., Moslehi, N., Mirmiran, P., Rahideh, S.T., and Azizi, F. (2024). Cigarette Smoking and Cardiovascular Disease Incidence and All-Cause Mortality: The Modifying Role of Diet Quality. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-18468-z"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/acer.13008","article-title":"Alcohol Toxicity in Diabetes and Its Complications: A Double Trouble?","volume":"40","author":"Munukutla","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-140-6-200403160-00011","article-title":"Effect of Alcohol Consumption on Diabetes Mellitus: A Systematic Review","volume":"140","author":"Howard","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3233\/JAD-230181","article-title":"Alcohol Use Disorder as a Risk Factor for Cognitive Impairment","volume":"94","author":"Wang","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1192\/j.eurpsy.2022.2344","article-title":"Cognitive Decline and Alcohol Consumption in the Aging Population-A Longitudinal Analysis of the Survey of Health, Ageing and Retirement in Europe","volume":"65","author":"Listabarth","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jdi.13375","article-title":"Combination of Alcohol and Glucose Consumption as a Risk to Induce Reactive Hypoglycemia","volume":"12","author":"Takeuchi","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"e1910319","DOI":"10.1001\/jamanetworkopen.2019.10319","article-title":"Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment","volume":"2","author":"Koch","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12967-022-03353-3","article-title":"The Impact of Heavy Alcohol Consumption on Cognitive Impairment in Young Old and Middle Old Persons","volume":"20","author":"Yen","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Devchand, P.R., Liu, T., Altman, R.B., FitzGerald, G.A., and Schadt, E.E. (2018). The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01093"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"e1799","DOI":"10.1212\/WNL.0000000000207069","article-title":"Pioglitazone Use and Reduced Risk of Dementia in Patients With Diabetes Mellitus With a History of Ischemic Stroke","volume":"100","author":"Ha","year":"2023","journal-title":"Neurology"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Saunders, A.M., Burns, D.K., and Gottschalk, W.K. (2021). Reassessment of Pioglitazone for Alzheimer\u2019s Disease. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.666958"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","article-title":"A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients with Alzheimer Disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Arch. Neurol."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Lin, H.-C., Chung, C.-H., Chen, L.-C., Wang, J.-Y., Chen, C.-C., Huang, K.-Y., Tsai, M.-H., Chien, W.-C., and Lin, H.-A. (2023). Pioglitazone Use Increases Risk of Alzheimer\u2019s Disease in Patients with Type 2 Diabetes Receiving Insulin. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-33674-2"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Kubis-Kubiak, A., Dyba, A., and Piwowar, A. (2020). The Interplay between Diabetes and Alzheimer\u2019s Disease-In the Hunt for Biomarkers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082744"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin\u2014A Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer\u2019s Disease Guest Editor: Davide Brambilla","volume":"34","author":"Sikora","year":"2017","journal-title":"Pharm. Res."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Adem, M.A., Decourt, B., and Sabbagh, M.N. (2024). Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer\u2019s Disease. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010099"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin Treatment Prevents Amyloid Plaque Deposition and Memory Impairment in APP\/PS1 Mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhao, J., Guo, F.-L., Gao, X., Xie, X., Liu, S., Yang, X., Yang, X., Zhang, L., and Ye, Y. (2020). Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.00170"},{"key":"ref_254","first-page":"178","article-title":"Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes","volume":"10","author":"Tran","year":"2017","journal-title":"Am. Health Drug Benefits"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"e3070","DOI":"10.1002\/dmrr.3070","article-title":"Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Treatment: Are They All the Same?","volume":"35","author":"Gentilella","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s12035-023-03698-w","article-title":"Exendin-4 Prevents Memory Loss and Neuronal Death in Rats with Sporadic Alzheimer-Like Disease","volume":"61","author":"Zago","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.npep.2018.07.003","article-title":"Neuroprotective Effects of the Novel GLP-1 Long Acting Analogue Semaglutide in the MPTP Parkinson\u2019s Disease Mouse Model","volume":"71","author":"Zhang","year":"2018","journal-title":"Neuropeptides"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1159\/000430199","article-title":"The Neuroprotective Effect of Liraglutide Is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP\/PKA\/CREB Pathway","volume":"36","author":"Bao","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/jnc.13169","article-title":"Liraglutide Is Neurotrophic and Neuroprotective in Neuronal Cultures and Mitigates Mild Traumatic Brain Injury in Mice","volume":"135","author":"Li","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Wici\u0144ski, M., Socha, M., Malinowski, B., W\u00f3dkiewicz, E., Walczak, M., G\u00f3rski, K., S\u0142upski, M., and Pawlak-Osi\u0144ska, K. (2019). Liraglutide and Its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer\u2019s Disease and Cerebral Ischemic Events. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051050"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11011-021-00879-1","article-title":"Neuroprotective Effects of Liraglutide against Inflammation through the AMPK\/NF-\u03baB Pathway in a Mouse Model of Parkinson\u2019s Disease","volume":"37","author":"Cao","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JPD-181503","article-title":"Semaglutide Is Neuroprotective and Reduces \u03b1-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson\u2019s Disease","volume":"9","author":"Zhang","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Tipa, R.O., Balan, D.-G., Georgescu, M.-T., Ignat, L.A., Vacaroiu, I.A., Georgescu, D.E., Raducu, L., Mihai, D.A., Chiperi, L.-V., and Balcangiu-Stroescu, A.-E. (2024). A Systematic Review of Semaglutide\u2019s Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094972"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s11095-022-03302-1","article-title":"Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative Diseases: A Narrative Review","volume":"39","author":"Mahapatra","year":"2022","journal-title":"Pharm. Res."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.3390\/cimb46060354","article-title":"Unlocking the Potential: Semaglutide\u2019s Impact on Alzheimer\u2019s and Parkinson\u2019s Disease in Animal Models","volume":"46","author":"Meca","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/1567205016666190913155950","article-title":"A Pilot Study of Exenatide Actions in Alzheimer\u2019s Disease","volume":"16","author":"Mullins","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimer\u2019s Disease: Study Protocol for a Randomised Controlled Trial (ELAD Study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13195-024-01573-x","article-title":"Inflammatory Proteins Associated with Alzheimer\u2019s Disease Reduced by a GLP1 Receptor Agonist: A Post Hoc Analysis of the EXSCEL Randomized Placebo Controlled Trial","volume":"16","author":"Koychev","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"111898","DOI":"10.1016\/j.mad.2023.111898","article-title":"A Feasibility Study of the Combination of Intranasal Insulin with Oral Semaglutide for Cognition in Older Adults with Metabolic Syndrome at High Dementia Risk- Study Rationale and Design","volume":"218","author":"Davidy","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Gejl, M., Brock, B., Egefjord, L., Vang, K., Rungby, J., and Gjedde, A. (2017). Blood-Brain Glucose Transfer in Alzheimer\u2019s Disease: Effect of GLP-1 Analog Treatment. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-17718-y"},{"key":"ref_271","first-page":"A4519","article-title":"Effects of Liraglutide on Neurodegeneration, Blood Flow and Cognition in Alzheimer\u2019s Disease\u2014Protocol for a Controlled, Randomized Double-Blinded Trial","volume":"59","author":"Egefjord","year":"2012","journal-title":"Dan. Med. J."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s40265-018-0937-z","article-title":"Empagliflozin: A Review in Type 2 Diabetes","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/dom.12307","article-title":"Efficacy and Safety of Empagliflozin for Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"16","author":"Liakos","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1753-0407.12278","article-title":"Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: An Overview of Safety and Efficacy Based on Phase 3 Trials","volume":"7","author":"Dailey","year":"2015","journal-title":"J. Diabetes"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40265-019-01148-3","article-title":"Dapagliflozin: A Review in Type 2 Diabetes","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1080\/14656566.2021.1953471","article-title":"Dapagliflozin for the Treatment of Type 2 Diabetes Mellitus\u2014An Update","volume":"22","author":"Nicholson","year":"2021","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s40265-014-0324-3","article-title":"Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes","volume":"74","author":"Plosker","year":"2014","journal-title":"Drugs"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/dom.13124","article-title":"Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis of Safety Data from Phase IIb\/III Clinical Trials","volume":"20","author":"Jabbour","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2337\/dc22-1705","article-title":"Association of Sodium-Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study","volume":"46","author":"Wu","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Koutentakis, M., Kuci\u0144ski, J., \u015awieczkowski, D., Surma, S., Filipiak, K.J., and G\u0105secka, A. (2023). The Ketogenic Effect of SGLT-2 Inhibitors\u2014Beneficial or Harmful?. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10110465"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.irn.2020.03.018","article-title":"A Role for Sodium Glucose Cotransporter 2 Inhibitors (SGLT2is) in the Treatment of Alzheimer\u2019s Disease?","volume":"155","author":"Esterline","year":"2020","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Lardaro, A., Quarta, L., Pagnotta, S., Sodero, G., Mariani, S., Del Ben, M., Desideri, G., Ettorre, E., and Baratta, F. (2024). Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081750"},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Avgerinos, K.I., Mullins, R.J., Vreones, M., Mustapic, M., Chen, Q., Melvin, D., Kapogiannis, D., and Egan, J.M. (2022). Empagliflozin Induced Ketosis, Upregulated IGF-1\/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics. Cells, 11.","DOI":"10.3390\/cells11213372"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase Inhibitors for the Treatment of Alzheimer\u2019s Disease: Getting On and Staying On","volume":"64","author":"Grossberg","year":"2003","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"ref_285","doi-asserted-by":"crossref","unstructured":"Liu, J., Chang, L., Song, Y., Li, H., and Wu, Y. (2019). The Role of NMDA Receptors in Alzheimer\u2019s Disease. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00043"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2165\/00003495-200666110-00015","article-title":"Memantine: A Review of Its Use in Alzheimer\u2019s Disease","volume":"66","author":"Robinson","year":"2006","journal-title":"Drugs"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"102203","DOI":"10.1016\/j.arr.2024.102203","article-title":"Comparative Efficacy, Tolerability and Acceptability of Donanemab, Lecanemab, Aducanumab and Lithium on Cognitive Function in Mild Cognitive Impairment and Alzheimer\u2019s Disease: A Systematic Review and Network Meta-Analysis","volume":"94","author":"Terao","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamaneurol.2023.3810","article-title":"Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial","volume":"80","author":"Lee","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1007\/s10072-024-07576-8","article-title":"Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer\u2019s Disease: A Meta-Analysis of Randomized Controlled Trials","volume":"45","author":"Marinheiro","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"105173","DOI":"10.1016\/j.jamda.2024.105173","article-title":"Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer\u2019s Disease","volume":"25","author":"Lee","year":"2024","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_291","first-page":"52","article-title":"The Effect of Holistic Therapy in Alzheimer\u2019s Disease","volume":"29","author":"Parlak","year":"2023","journal-title":"Altern. Ther. Health Med."},{"key":"ref_292","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2020). Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment. Molecules, 25.","DOI":"10.3390\/molecules25245789"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11892-014-0476-2","article-title":"Alzheimer\u2019s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions","volume":"14","author":"Jayaraman","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4239\/wjd.v12.i6.745","article-title":"Alzheimer\u2019s Disease and Type 2 Diabetes Mellitus: Pathophysiologic and Pharmacotherapeutics Links","volume":"12","author":"Rojas","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"e20230032","DOI":"10.1590\/1980-5764-dn-2023-0032","article-title":"Brain Insulin Resistance and Alzheimer\u2019s Disease: A Systematic Review","volume":"18","author":"Andrade","year":"2024","journal-title":"Dement. Neuropsychol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-017-0319-x","article-title":"The Clinical Significance of Plasma Clusterin and A\u03b2 in the Longitudinal Follow-up of Patients with Alzheimer\u2019s Disease","volume":"9","author":"Hsu","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2174\/1567205016666191024141757","article-title":"Plasma Clusterin as a Potential Biomarker for Alzheimer\u2019s Disease-A Systematic Review and Meta-Analysis","volume":"16","author":"Shi","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2174\/1389557523666230412083123","article-title":"Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases","volume":"23","author":"Zhu","year":"2023","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_299","doi-asserted-by":"crossref","unstructured":"Lauretti, E., Dincer, O., and Pratic\u00f2, D. (2020). Glycogen Synthase Kinase-3 Signaling in Alzheimer\u2019s Disease. Biochim. Biophys. Acta Mol. Cell Res., 1867.","DOI":"10.1016\/j.bbamcr.2020.118664"},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41380-022-01531-9","article-title":"Dissecting the Clinical Heterogeneity of Early-Onset Alzheimer\u2019s Disease","volume":"27","author":"Sirkis","year":"2022","journal-title":"Mol. Psychiatry"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11955\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:27:51Z","timestamp":1760113671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":300,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252211955"],"URL":"https:\/\/doi.org\/10.3390\/ijms252211955","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]}}}